BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Gizawy SA, El-Maghraby GM, Hedaya AA. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and in-vitro characterization. Pharm Dev Technol 2019;24:1287-98. [PMID: 31507232 DOI: 10.1080/10837450.2019.1667385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Jadhav S, Yenorkar N, Bondre R, Karemore M, Bali N. Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics. Journal of Drug Delivery Science and Technology 2022;71:103315. [DOI: 10.1016/j.jddst.2022.103315] [Reference Citation Analysis]
2 Saini K, Modgill N, Singh KK, Kakkar V. Tetrahydrocurcumin Lipid Nanoparticle Based Gel Promotes Penetration into Deeper Skin Layers and Alleviates Atopic Dermatitis in 2,4-Dinitrochlorobenzene (DNCB) Mouse Model. Nanomaterials (Basel) 2022;12:636. [PMID: 35214966 DOI: 10.3390/nano12040636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Abd-Elsalam WH, Ibrahim RR. Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections. Int J Pharm 2021;609:121214. [PMID: 34678396 DOI: 10.1016/j.ijpharm.2021.121214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Mady OY, Al-Shoubki AA, Donia AA. An Industrial Procedure for Pharmacodynamic Improvement of Metformin HCl via Granulation with Its Paracellular Pathway Enhancer Using Factorial Experimental Design. Drug Des Devel Ther 2021;15:4469-87. [PMID: 34764634 DOI: 10.2147/DDDT.S328262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang Z, Wu L, Wang W, Wang W, Fu F, Zhang X, Huang Y, Pan X, Wu C. Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles. Pharm Dev Technol 2021;:1-10. [PMID: 34694203 DOI: 10.1080/10837450.2021.1998114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gharpure S, Ankamwar B. Use of nanotechnology in combating coronavirus. 3 Biotech 2021;11:358. [PMID: 34221822 DOI: 10.1007/s13205-021-02905-6] [Reference Citation Analysis]
7 Scioli Montoto S, Muraca G, Di Ianni M, Couyoupetrou M, Pesce G, Islan G, Chain C, Vela M, Ruiz M, Talevi A, Castro G. Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices. Journal of Drug Delivery Science and Technology 2021;63:102470. [DOI: 10.1016/j.jddst.2021.102470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Delshadi R, Bahrami A, McClements DJ, Moore MD, Williams L. Development of nanoparticle-delivery systems for antiviral agents: A review. J Control Release 2021;331:30-44. [PMID: 33450319 DOI: 10.1016/j.jconrel.2021.01.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
9 Tortella GR, Rubilar O, Diez MC, Padrão J, Zille A, Pieretti JC, Seabra AB. Advanced Material Against Human (Including Covid-19) and Plant Viruses: Nanoparticles As a Feasible Strategy. Glob Chall 2020;:2000049. [PMID: 33614127 DOI: 10.1002/gch2.202000049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhou J, Krishnan N, Jiang Y, Fang RH, Zhang L. Nanotechnology for virus treatment. Nano Today 2021;36:101031. [PMID: 33519948 DOI: 10.1016/j.nantod.2020.101031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
11 Taylor JM, Scale K, Arrowsmith S, Sharp A, Flynn S, Rannard S, Mcdonald TO. Using pyrene to probe the effects of poloxamer stabilisers on internal lipid microenvironments in solid lipid nanoparticles. Nanoscale Adv 2020;2:5572-7. [DOI: 10.1039/d0na00582g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]